Section of Endocrinology
Cancer and the Adrenal Cortex In recent years interest has focused on the development of bilateral adrenocortical hyperplasia in patients with cancer, commonly bronchogenic carcinoma, leading in many instances to hypokalhmic alkalosis and occasionally to florid Cushing's syndrome. This striking endocrine abnormality is encountered in only a small minority ofpatients with bronchogenic carcinoma. In a survey of 100 consecutive admissions to University College Hospital in which this diagnosis was confirmed only 2 were found to have this complication.
Adrenal Function in Unselected Patients with Bronchogenic Carcinoma
Much less attention has been paid to minor degrees of alteration of adrenal function in cancer patients. The early investigations of Dobriner and his colleagues showed that corticotrophin stimulation produced an excessive hydroxycorticoid response in some of these patients. 1 1-hydroxy-,etiocholanolone was present in the urine of cancer patients and was not found in normal controls (Dobriner 1952 ). Subsequent investigators have confirmed that plasma concentration or urinary excretion of hydroxycorticoids may be raised in patients with cancer, particularly in those with bronchogenic carcinoma (Bagshawe 1960 , Werk et al. 1963 ).
An excessive rise of plasma 17-hydroxycorticoids during a four-hour intravenous corticotrophin stimulation test has been observed in unselected cases of bronchogenic carcinoma; this was not seen in patients with other types of neoplasm (Belsky & Marks 1962 , Segaloff et al. 1962 , Hymes & Doe 1962 . The nearer these patients are to death the greater the adrenal response, according to Hymes & Doe (1962) , but this is denied by Werk et al. (1963) . Sudden increase in plasma 17-hydroxycorticoids five to ten weeks before death has also been noted (Werk et al. 1963) . Diurnal variation of plasma cortisol concentration is lost in patients with bronchogenic carcinoma but not in equally ill patients without cancer (Hymes & Doe 1962 , Werk et al. 1963 .
Another feature of patients with bronchogenic carcinoma has been commented on by Hatch et al. (1965) , who have noted that some patients with an elevated plasma corticoid concentration have a response to a water load test resembling that of patients with Addison's disease. Others have suspected adrenocortical insufficiency in patients who proved on investigation to have a high plasma corticosteroid concentration (Friedman et al. 1965 ).
In some of these patients the pituitary content of corticotrophin has been found to be high (Belsky & Marks 1962 , Pfohl & Doe 1963 , in contradistinction to the situation in other patients (to be considered later) with oat cell carcinoma of the lung where the tumour content of corticotrophin is high and pituitary content is very low. We could perhaps regard this as a stress response to the presence of cancer but it is curious that it occurs with bronchogenic carcinoma and not with other cancers. Secondary Cushing's Syndrome Major interest has been focused on the minority of patients with anaplastic (oat cell) carcinoma of the lung who have an excessive adrenocortical secretion of cortisol which in some cases leads to changes in the patient's appearance indistinguishable clinically from Cushing's syndrome, but usually distinguishable biochemically by the presence of hypokalhmic alkalosis.
Although this is the commonest association, neoplasms other than oat cell carcinoma of the bronchus can result in excessive adrenal activity; these include pancreas, ovary, thymus, thyroid, parathyroid, testis, prostate, breast, cesophagus, colon, sympathicoblastoma and primary tumours of the trachea.
The complete clinical picture of Cushing's syndrome is seen in some of these patients, others show some features of this syndrome, others none. Only 2 of our 10 cases had a cushingoid appearance (Friedman et al. 1966). (Edema is a feature found in many of those who are not cushingoid. A few have been pigmented.
The most consistent biochemical abnormality found in this complication of cancer is hypoka-Itmic alkalosis but this is not invariable (Rosenthal 1957 , Scholz & Bahn 1959 , Friedman et al. 1965 . Plasma pH has been elevated in most of the cases in which it has been measured. In one case a plasma pH of 7 72 was claimed (Mach et al. 1958) . The metabolic abnormality appears to be caused solely by the high plasma concentration of cortisol (Christy & Laragh 1961) although increased excretion of corticosterone has occasionally been noted (Cost 1963 , Friedman et al. 1966 . Raised excretion of tetrahydrocorticosterone was observed in 2 of 5 of our patients whose urine was examined chromatographically. Aldosterone secretion is not elevated, apart from the single patient reported by Webster et al. (1959) ; it was not elevated in any of our patients.
Hypokalkmic alkalosis is rare in primary
Cushing's syndrome and its occurrence in a patient with the clinical features of Cushing's syndrome should alert the physician to the probability of an underlying carcinoma. The sex incidence is also of assistance in diagnosis: true Cushing's syndrome is much commoner in females than males whereas adrenal hyperplasia sscondary to cancer is much commoner in males.
Most of these patients have hyperglyctemia and glycosuria without ketoacidosis. Their diabetes tends to be more severe than that encountered in patients with true Cushing's syndrome. This is probably related to their state of potassium depletion which impairs glucose tolerance. Another feature in which patients with true Cushing's syndrome differ from those with adrenal hyperplasia secondary to cancer is in the relationship between plasma corticoid concentration and the amount of 17-ketogenic or free cortisol excreted in the urine. In the terminal stage of the disease the amount of 17-ketogenic steroid excreted in the urine is less than would be expected from the plasma level, when compared with primary Cushing's syndrome; the relationship changes with progression of the disease (Figs 1 & 2) . This discrepancy could be explained by an increase in protein binding, so that less free steroid is available for filtration by the glomeruli. An alternative explanation would be that degradation of cortisol is reduced in a liver full of metastases. A similar observation was made in a series of unselected patients with bronchogenic carcinoma by Hymes & Doe (1962) , and Hatch (1965) managed to find increased protein binding of cortisol in 6 of 40 patients. Observation of this discrepancy may offer another clue to diagnosis, since the admittedly rather scanty information available suggests that this is not a feature of true Cushing's syndrome (Fig 1) .
The evidence is now conclusive that this metabolic complication of cancer is due to the secretion of a polypeptide with corticotrophin-like activity by the tumour itself, since this has been extracted from the tumour, metastases and blood (Holub & Katz 1961 , Meador et al. 1962 , Marks et al. 1963 , Jarett et al. 1964 ). An adrenal weightmaintaining factor has also been reported in the plasma (Christy 1961 , Holub & Katz 1961 , Meador et al. 1962 , Liddle et al. 1963 . Pituitary content of corticotrophin is very low. Further evidence in favour of secretion of corticotrophin by the tumour rather than by the pituitary is the remission of symptoms and of the electrolyte abnormality that follows irradiation or surgical removal of the tumour (Engel & Kahana 1963, 6 0'1-.
Mi&i & Arsenijevic 1963) whereas hypophysectomy is without effect (Liddle et al. 1965 ). Most, but not all, patients with this metabolic complication of bronchogenic carcinoma fail to respond to corticotrophin by increased plasma or urinary corticosteroid concentration and to pituitary suppression by dexamethasone or A'9a-fluorohydrocortisone (Friedman et al. 1966 ).
These patients with hypokalkmic alkalosis have an endocrine response to cancer which is quantitatively and qualitatively different from that of the patients discussed earlier. The tumour itself is producing a substance with corticotrophinlike activity. This substance is not necessarily identical chemically with pituitary corticotrophin, which has a sequence of 39 amino-acid residues. This length of chain is not essential for corticotrophin activity since a polypeptide containing only 13 amino-acid sequences has corticotrophinlike activity (Guttman & Boissonnas 1959) . Other polypeptides are known to be secreted by tumours. One has a parathyroid-hormone-like activity; the natural parathyroid hormone has a sequence of 82 amino acids; others secrete a substance with vasopressin-like activity but this is a simpler polypeptide, the naturally-occurring substance having a sequence of 9 amino acids. We have been conditioned to believe that highly complex substances like these hormones are produced by highly differentiated cells, but in this disease an undifferentiated tumour cell has apparently reverted to the totipotentiality of the primitive cell and probably reproduces all manner of complex polypeptides, some of which by chance have biological activity, of which corticotrophin-like action is one example.
Patients with bronchogenic carcinoma complicated by adrenal hyperplasia die more rapidly than those with equal primary and secondary involvement with this cancer; the average length of survival from first attendance in the outpatient department in our 9 patients was twenty-four days. Although evidence that glucocorticoids accelerate the spread of cancer is circumstantial only, there is some evidence that steroids alter the manner of spread of such cancers as carcinoma of the breast (Iversen & Hjort 1958 , Sherlock & Hartmann 1962 which metastasize to the spleen in the cortisone-treated patient, a rare site for secondaries in the patient not on cortisone.
Since this complication appreciably diminishes life expectancy it appears reasonable, in patients who cannot be effectively treated by surgery, radiotherapy or chemotherapy, to perform bilateral adrenalectomy. This has been done with some success in some cases (Nabarro 1957 , Brenton 1963 ), but not in others (Friedman et al. 1966 ). Treatment with a specific inhibitor of adrenocortical synthesis, mp'DDD, has reduced cortisol secretion in one case secondary to carcinoma of the ovary (Nichols et al. 1962) .
In summary, the suggestion is advanced that quantitative alteration of adrenal function is not a sudden and rare event confined to patients with oat cell carcinoma of the lung, and occasionally other neoplasms, but that it is a common occurrence in bronchogenic carcinoma of all cell types due to pituitary stimulation; in most patients it does not give rise to overt metabolic disturbance but occasionally it may paradoxically be associated with symptoms of adrenal insufficiency. In a minority of patients having oat cell carcinoma the tumour itself begins to secrete a corticotrophin in large quantities which causes such intense adrenal production of cortisol and perhaps of other metabolites that gross metabolic changes ensue. Lowering of the degree of protein binding and retarded degradation in a liver full of metastases may cause large quantities of unbound cortisol to be present in the circulation in some instances, whilst increased protein binding may lower the plasma concentration of biologically active cortisol in others, thus giving rise to the confusing clinical pictures often encountered in these patients. Acknowledgments: I am grateful to Dr E W Emery and Dr J N Godlee, radiotherapists, to Dr H Nicholson and Dr P J D Heaf, chest physicians, and to other physicians and surgeons of University College Hospital who have given me access to patients with carcinoma of the bronchus. The Hypoglycsemia ofNon-endocrine Origin (Non-islet Cell Tumours) Hypoglycamia secondary to 'non-islet cell' neoplasms is well recognized. Though symptoms often develop late in the course of the illnesswhen they may be attributed to cerebral secondariesthey are frequently the cause of presentation. When this occurs, the anamnesis may be indistinguishable from that of insulinoma and a cause of diagnostic difficulties. Far commoner, and more important, is failure to suspect hypoglyc,Tmia and initiate investigations. Only increased clinical awareness ofthe diverse symptomatology of hypoglycemia can overcome this.
This report is based upon a survey of the literature (Table 1 ) and 9 personal cases of 'non-islet cell' neoplasms (3 of carcinoma and 6 of fibrosarcoma) producing hypoglycaemia, of which some details have already been published in 7 (Samols 1963 , Marks et al. 1965 .
Although more than 200 cases have been described, the mechanism by which they produce hypoglycxmia is still poorly understood. It is unlikely to be the same in all cases, but the evidence suggests that in the majority hypoglycemia is due to direct or indirect inhibition of hepatic glucose release (Butterfield et al. 1960 , Samols 1963 , Froesch et al. 1963 ) by a humoral factor produced by the tumour which may, or (Marks & Rose 1965) and is due to the production of one or more hormonally active substances by the neoplastic tissues.
Epithelial Tumours
Only an infinitesimally small proportion of carcinomata arising elsewhere than in the pancreas are associated with hypoglycemia, but in them it may be their mode of presentation (Marks et al. 1965 ) and major cause of symptoms. Though many types of tumour are involved, e.g. lung, stomach and cecum, three deserve special attention:
(1) Primary hepatic carcinoma: Cases have been reported from all over the world, but most have occurred in the Far Eastpossibly reflecting the high local incidence of this type of tumour. Death is seldom long delayed once hypoglycemia has appeared. Polycythemia is a common associated abnormality and hypercalcaemia may occur (Becker et al. 1963 ).
(2) Adrenal tumour: These tumours are usually malignant, but occasionally benign, and invariably large (average weight 1 -8 kg). Over-production of adrenal steroids is the rule but, though virilism is often present, Cushing's syndrome is rare and in some cases clinical evidence of adrenocortical over-activity is entirely lacking.
(3) Acinar carcinoma ofthe pancreas: Though few cases of primary acinar tumour have been recognized as a cause of spontaneous hypoglycaemia, they are of especial interest since, like pancreatic metastases (Yalow & Berson 1965) but in contrast to other hypoglycmmia-producing
